AltruBio raises up to $225M in Series B financing led by BVF Partners LP and other investors to advance the clinical development of novel immune checkpoint enhancer program
Amount Raised
$225 Million
Round Type
Series B
San FranciscoBiotechnologyHealth CareTherapeuticsInvestors
Description
AltruBio Inc. announced an oversubscribed Series B financing of up to $225 million led by BVF Partners LP, with participation from new investors RA Capital Management, Cormorant Asset Management, Soleus Capital, and existing investors aMoon Fund and Blackstone Multi-Asset Investing. The funds will be used to support ongoing and planned Phase 2 clinical trials of immune checkpoint enhancer ALTB-268 in ulcerative colitis.
Quick answer
AltruBio Inc. raised $225 Million in a Series B round, dated May 21, 2024. Investors: Blackstone Multi Asset Investing, A Moon Fund, Soleus Capital, Cormorant Asset Management, RA Capital Management and BVF Partners LP. AltruBio Inc. is based in San Francisco, California, United States.
- How much did AltruBio Inc. raise?
- AltruBio Inc. raised $225 Million in a Series B round on May 21, 2024.
- Who invested in AltruBio Inc?
- Blackstone Multi Asset Investing, A Moon Fund, Soleus Capital, Cormorant Asset Management, RA Capital Management and BVF Partners LP are named as investors in this round.
- What does AltruBio Inc. do?
- AltruBio is developing first-in-class immune-modulators targeting diseases of #immunology and #inflammation.
- Where is AltruBio Inc. based and how big is it?
- AltruBio Inc. is based in San Francisco, California, United States.
- Who are the decision-makers at AltruBio Inc?
- Fundz holds 1 contact at AltruBio Inc. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as AltruBio Inc. that raised within 45 days of this round, from Fundz verified event records.
- Virpax Pharmaceuticals raised $2.5M on July 5, 2024.
- NGM Bio raised $73M on July 5, 2024.
- Beacon Therapeutics raised $170M (Series B) on July 3, 2024.
- Cartesian Therapeutics, Inc. raised $130M on July 2, 2024.
- N-Power Medicine raised $72M (Series B) on July 1, 2024.
- Scorpion Therapeutics raised $126M on July 1, 2024.
Who to call at AltruBio Inc., and when
A new round usually means AltruBio Inc. is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day AltruBio Inc. raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at AltruBio Inc., from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at AltruBio Inc.. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment AltruBio Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansAltruBio Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.